Emergent BioSolutions Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Emergent BioSolutions Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Emergent BioSolutions Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $18.7M, a 90.4% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $18.7M -$176M -90.4% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $191M +$6.8M +3.68% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $194M +$3M +1.57% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $194M +$153M +376% Sep 30, 2023 10-Q 2023-12-11
Q2 2023 $195M +$143M +279% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $185M +$128M +223% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $191M +$133M +229% Dec 31, 2022 10-K 2024-03-08
Q3 2022 $40.8M -$61.4M -60.1% Sep 30, 2022 10-Q 2023-12-11
Q2 2022 $51.3M -$58.6M -53.3% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $57.1M -$54.3M -48.7% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $58.2M -$55.2M -48.7% Dec 31, 2021 10-K/A 2023-12-11
Q3 2021 $102M -$4.2M -3.95% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $110M +$8.3M +8.17% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $111M +$29.6M +36.2% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $113M +$23.1M +25.6% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $106M +$39M +57.9% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $102M +$45.2M +80.1% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $81.8M +$35.8M +77.8% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $90.3M +$76.6M +559% Dec 31, 2019 10-K 2021-02-19
Q3 2019 $67.4M +$61.6M +1071% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $56.4M +$51.5M +1058% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $46M +$42.9M +1394% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $13.7M +$7.6M +125% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $5.76M -$887K -13.4% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 $4.87M +$1.15M +30.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $3.08M +$41K +1.35% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $6.1M +$3.62M +146% Dec 31, 2017 10-K 2019-02-22
Q3 2017 $6.64M +$4.86M +273% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $3.72M +$1.88M +102% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $3.04M +$920K +43.5% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $2.48M +$328K +15.2% Dec 31, 2016 10-K 2018-02-23
Q3 2016 $1.78M -$5.06M -74% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $1.85M -$5.4M -74.5% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $2.12M -$5.58M -72.5% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $2.16M -$6.06M -73.8% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $6.84M -$1.5M -17.9% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $7.25M -$1.52M -17.3% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $7.7M -$1.67M -17.8% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $8.22M +$4.84M +144% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $8.34M +$7.9M +1791% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $8.77M +$8.21M +1460% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $9.37M +$8.79M +1534% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $3.37M +$2.64M +362% Dec 31, 2013 10-K/A 2015-03-09
Q3 2013 $441K -$309K -41.2% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $562K -$151K -21.2% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $573K -$172K -23.1% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $730K -$77K -9.54% Dec 31, 2012 10-K 2014-03-10
Q3 2012 $750K +$43K +6.08% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 $713K +$1K +0.14% Jun 30, 2012 10-Q 2012-08-03
Q1 2012 $745K Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $807K -$391K -32.6% Dec 31, 2011 10-K 2013-03-08
Q3 2011 $707K Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $712K Jun 30, 2011 10-Q 2011-08-05
Q4 2010 $1.2M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.